Cargando…

Alzheimer’s Disease Severity Is Associated with an Imbalance in Serum Levels of Enzymes Regulating Plasmin Synthesis

Alzheimer’s disease (AD) is a central nervous system (CNS) disease characterized by loss of memory, cognitive functions, and neurodegeneration. Plasmin is an enzyme degrading many plasma proteins. In the CNS, plasmin may reduce the accumulation of beta amyloid (Aβ) and have other actions relevant to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Angelucci, Francesco, Veverova, Katerina, Katonová, Alžbeta, Piendel, Lydia, Vyhnalek, Martin, Hort, Jakub
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505552/ https://www.ncbi.nlm.nih.gov/pubmed/36145295 http://dx.doi.org/10.3390/ph15091074

Ejemplares similares

Serum PAI-1/BDNF Ratio Is Increased in Alzheimer’s Disease and Correlates with Disease Severity
por: Angelucci, Francesco, et al.
Publicado: (2023)

Effect of a Vegan Diet on Alzheimer’s Disease
por: Katonova, Alzbeta, et al.
Publicado: (2022)

An update on mobile applications collecting data among subjects with or at risk of Alzheimer's disease
por: Piendel, Lydia, et al.
Publicado: (2023)

Emotional prosody recognition is impaired in Alzheimer’s disease
por: Amlerova, Jana, et al.
Publicado: (2022)

Antibiotics, gut microbiota, and Alzheimer’s disease
por: Angelucci, Francesco, et al.
Publicado: (2019)

Amyloid beta soluble forms and plasminogen activation system in Alzheimer’s disease: Consequences on extracellular maturation of brain‐derived neurotrophic factor and therapeutic implications
por: Angelucci, Francesco, et al.
Publicado: (2018)

Compromised autophagy and mitophagy in brain ageing and Alzheimer’s diseases
por: Caponio, Domenica, et al.
Publicado: (2022)

Moderating effect of cognitive reserve on brain integrity and cognitive performance
por: Nelson, Monica E., et al.
Publicado: (2022)

Administration of pre/probiotics with conventional drug treatment in Alzheimer’s disease
por: Hort, Jakub, et al.
Publicado: (2019)

MicroRNAs in Alzheimer’s Disease: Diagnostic Markers or Therapeutic Agents?
por: Angelucci, Francesco, et al.
Publicado: (2019)

Analysis of lipophilic fluorescent products in blood of Alzheimer's disease patients
por: Chmátalová, Zuzana, et al.
Publicado: (2016)

STUDIES OF THE PLASMIN SYSTEM : II. INHIBITION OF PLASMIN BY SERUM OR PLASMA
por: Norman, Philip S.
Publicado: (1958)

Famous Landmark Identification in Amnestic Mild Cognitive Impairment and Alzheimer's Disease
por: Sheardova, Katerina, et al.
Publicado: (2014)

Identification and Characterization of Plasmin-Independent Thrombolytic Enzymes
por: Hassan, Md. Mehedi, et al.
Publicado: (2020)

A new assay to evaluate microvesicle plasmin generation capacity: validation in disease with fibrinolysis imbalance
por: Cointe, Sylvie, et al.
Publicado: (2018)

HIGH OSMOLARITY EFFECT OF INTRAVITREAL PLASMIN ENZYME ON RABBIT RETINA
por: ASAMI, TETSU, et al.
Publicado: (2015)

Spatial Pattern Separation Testing Differentiates Alzheimer’s Disease Biomarker-Positive and Biomarker-Negative Older Adults With Amnestic Mild Cognitive Impairment
por: Laczó, Martina, et al.
Publicado: (2021)

Six genetically linked mutations in the CD36 gene significantly delay the onset of Alzheimer's disease
por: Šerý, Omar, et al.
Publicado: (2022)

QUANTITATIVE STUDIES ON THE TOTAL PLASMIN AND THE TRYPSIN INHIBITOR OF HUMAN BLOOD SERUM : I. METHODS FOR THE TITRATION OF TOTAL PLASMIN AND OF TRYPSIN INHIBITOR
por: Todd, Edgar W.
Publicado: (1949)

Cell Surface Remodeling by Plasmin: A New Function for an Old Enzyme
por: Deryugina, Elena I., et al.
Publicado: (2012)

Vascular Cognitive Impairment: Information from Animal Models on the Pathogenic Mechanisms of Cognitive Deficits
por: Hort, Jakub, et al.
Publicado: (2019)

Evidences for a Role of Gut Microbiota in Pathogenesis and Management of Epilepsy
por: Amlerova, Jana, et al.
Publicado: (2021)

Plasmin and Articular Cartilage
por: Chrisman, O. Donald, et al.
Publicado: (1962)

STUDIES OF THE PLASMIN SYSTEM : III. PHYSICAL PROPERTIES OF THE TWO PLASMIN INHIBITORS IN PLASMA
por: Norman, Philip S., et al.
Publicado: (1958)

Elevation of Plasmin-α2-plasmin Inhibitor Complexes in Patients with AL Amyloidosis
por: Miyazaki, Kanji, et al.
Publicado: (2018)

Peptides with 6-Aminohexanoic Acid: Synthesis and Evaluation as Plasmin Inhibitors
por: Purwin, Maciej, et al.
Publicado: (2016)

Basal Forebrain Atrophy Contributes to Allocentric Navigation Impairment in Alzheimer’s Disease Patients
por: Kerbler, Georg M., et al.
Publicado: (2015)

Serum proteases prevent bacterial biofilm formation: role of kallikrein and plasmin
por: Arenas, Jesús, et al.
Publicado: (2021)

Czech Brain Aging Study (CBAS): prospective multicentre cohort study on risk and protective factors for dementia in the Czech Republic
por: Sheardova, Katerina, et al.
Publicado: (2019)

Contribution of Memory Tests to Early Identification of Conversion from Amnestic Mild Cognitive Impairment to Dementia
por: Vyhnalek, Martin, et al.
Publicado: (2022)

Different Profiles of Spatial Navigation Deficits In Alzheimer’s Disease Biomarker-Positive Versus Biomarker-Negative Older Adults With Amnestic Mild Cognitive Impairment
por: Laczó, Martina, et al.
Publicado: (2022)

Plasmin inhibitor interactions. The effectiveness of alpha2-plasmin inhibitor in the presence of alpha2-macroglobulin
Publicado: (1977)

STUDIES ON THE INHIBITION OF PROTEOLYTIC ENZYMES BY SERUM : I. THE MECHANISM OF THE INHIBITION OF TRYPSIN, PLASMIN, AND CHYMOTRYPSIN BY SERUM USING FIBRIN TAGGED WITH I(131)AS A SUBSTRATE
por: Shulman, N. Raphael
Publicado: (1952)

Spinosin Attenuates Alzheimer’s Disease-Associated Synaptic Dysfunction via Regulation of Plasmin Activity
por: Cai, Mudan, et al.
Publicado: (2020)

Mild Behavioral Impairment Is Associated With Atrophy of Entorhinal Cortex and Hippocampus in a Memory Clinic Cohort
por: Matuskova, Veronika, et al.
Publicado: (2021)

Corrigendum: Mild Behavioral Impairment Is Associated With Atrophy of Entorhinal Cortex and Hippocampus in a Memory Clinic Cohort
por: Matuskova, Veronika, et al.
Publicado: (2022)

Blood markers of oxidative stress in Alzheimer's disease
por: Skoumalová, Alice, et al.
Publicado: (2012)

THE INACTIVATION OF COMPLEMENT AND ITS COMPONENTS BY PLASMIN
por: Pillemer, Louis, et al.
Publicado: (1953)

Does plasmin have anticoagulant activity?
por: Hoover-Plow, Jane
Publicado: (2010)

Assessing Plasmin Generation in Health and Disease
por: Miszta, Adam, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_avjkr4kr68umbcmpngnra2r7eq